Journal Information
Most cited
Data available in articles published since the year 2014
8
Good clinical practice recommendations for proton pump inhibitor prescription and deprescription. A review by experts from the AMG
L.R. Valdovinos-García, A.S. Villar-Chávez, F.M Huerta-Iga, M. Amieva-Balmori, J.S. Arenas-Martínez, R. Bernal-Reyes, E. Coss-Adame, O. Gómez-Escudero, ... M.R. Zavala-Solares
Rev Gastroenterol Mex. 2025;90:111-30
8
Full text access
6
Clinical description of adults with eosinophilic esophagitis treated at a Chilean university center
C. von Muhlenbrock, P. Núñez, R. Quera, J. Venegas, N. Pacheco, K. Herrera, F. Castro
Rev Gastroenterol Mex. 2025;90:8-14
6
Full text access
6
Pharmacologic treatment of irritable bowel syndrome. Position statement of the Asociación Mexicana de Gastroenterología, 2024
J.M. Remes-Troche, E. Coss-Adame, M. Schmulson, K.R. García-Zermeño, M. Amieva-Balmori, R. Carmona-Sánchez, O. Gómez-Escudero, P.C. Gómez-Castaños, ... A.S. Villar-Chávez
Rev Gastroenterol Mex. 2025;90:77-110
6
Full text access
5
Good clinical practice recommendations for the management of gastroesophageal reflux disease. A Latin American expert review
M.A. Valdovinos-Díaz, A. Hani, C. Defilippi-Guerra, L. Fernando-Pineda, J.M. Remes-Troche, A. Riquelme, L.J. Abrahão-Junior, L. Aguilar-Paiz, ... J.S. Arenas-Martínez
Rev Gastroenterol Mex. 2025;90:288-308
5
Full text access
4
Real-world experience with the diagnosis of bile acid malabsorption (BAM) using serum 7-alpha-C4 and 48-hour stool bile acids
G. Mendoza-Domínguez, Z.M. Garrido-Santos, C. Lau, R. Balbuena, A.D. Santana-Vargas, M. Schmulson-Wasserman
Rev Gastroenterol Mex. 2025;90:169-75
4
Full text access
4
Dietary characteristics of Mexican patients with irritable bowel syndrome: Is there a distinction from the general population?
M. Amieva-Balmori, G.P. Martínez-Pérez, M.R. Francisco, A. Triana-Romero, A.A. Ortiz-Lorenzo, G.A. Hernández-Ramírez, J.A. Martínez-Conejo, G.A. Violante-Hernández, ... J.M. Remes-Troche
Rev Gastroenterol Mex. 2025;90:182-91
4
Full text access
4
Cannabinoid hyperemesis syndrome: A review
R.A. Jiménez-Castillo, S. Arumugam, J.M. Remes-Troche, T. Venkatesan
Rev Gastroenterol Mex. 2025;90:214-26
4
Full text access
3
Transitioning from NAFLD to MAFLD to MASLD in the Mexican population
B.A. Priego-Parra, R. Bernal-Reyes, M.E. Icaza-Chávez, S.E. Martínez-Vázquez, J.M. Remes-Troche
Rev Gastroenterol Mex. 2025;90:153-6
3
Full text access
3
Treatment of small intestinal bacterial overgrowth in Chilean patients with irritable bowel syndrome: A prospective and comparative study
C. von Muhlenbrock, G. Landskron, A.M. Madrid
Rev Gastroenterol Mex. 2025;90:54-62
3
Full text access
2
Hemostatic powder efficacy for the endoscopic management of malignant upper gastrointestinal bleeding
J.P. Pérez-Macías, M.E. Ramírez-Solís, A.I. Hernández-Guerrero, J.G. Dela Mora-Levy, W.D. Torrecilla-Ramírez, B.A. Sánchez-Jiménez, G.M. Salgado-Castellón
Rev Gastroenterol Mex. 2025;90:199-206
2
Full text access

